Jeremy Barr completed his PhD in microbiology at The University of Queensland in 2011. He then moved to San Diego, USA to complete a postdoctoral position under the tutelage of Prof. Forest Rohwer at San Diego State University. While there he studied the interactions of bacteriophage with mucosal surfaces and was involved in a world-first phage therapy case treating a patient with disseminated, multidrug-resistant infection. In 2016, he joined Monash University's School of Biological Sciences where he is currently an Associate Professor and Group Leader. His research group studies bacteriophages and their interactions with their bacterial hosts and the human body. In 2020, he joined the Centre to Impact AMR where he leads the Monash Phage Foundry as an in-house manufacturing facility. In 2024, he was awarded a prestigious NHMRC Investigator Fellow L1 in recognition of their translational work using phage therapy to combat antimicrobial resistance. In 2025, he was promoted to full Professor at Monash University in the School of Biological Sciences.
Back to All Events